Company Filing History:
Years Active: 2008
Title: Innovations of Gilbert Deleage in Structural Proteins
Introduction: Gilbert Deleage is a notable inventor based in Lyons, France. He has made significant contributions to the field of biotechnology, particularly in the development of structural proteins. His work focuses on enhancing the infectivity of adeno-associated viruses, which has important implications for gene therapy and medical research.
Latest Patents: Gilbert Deleage holds a patent for a structural protein of adeno-associated virus (AAV) that includes at least one mutation to increase the virus's infectivity. This innovation is crucial for advancing therapeutic applications and improving the efficacy of viral vectors in gene therapy. He has 1 patent to his name.
Career Highlights: Deleage is associated with Medigene AG, a company that specializes in immunotherapy and innovative treatments for cancer. His role at Medigene AG allows him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations: Throughout his career, Gilbert Deleage has worked alongside esteemed colleagues such as Michael Hallek and Martin Ried. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion: Gilbert Deleage's work in the development of structural proteins for adeno-associated viruses exemplifies the impact of innovation in biotechnology. His contributions continue to influence the landscape of gene therapy and medical research.